Step 12: Maintain regular check-ups

Return to Index Step 1: Taking Charge Step 2: What is Diabetes?Step 3: Symptoms of Diabetes Step 4: Diagnosing Diabetes Step 5: Your Management Program Step 6: Use Insulin Every Day Step 7: Follow a Meal Plan Step 8: Monitor Blood Glucose Step 9: Exercise is Important!Step 10: Recognize Medical Emergencies Step 11: Long-Term Complications Step 12: Maintain Regular Check-ups Step 13: The Healthcare Team Key Points Glossary

*Close Menu*

To keep an eye on potential complications of diabetes, people with diabetes must have regular health check-ups and tests. These will continue through adult life. Here is a general program of continuing care recommended by the American Diabetes Association.

Every 3 to 6 months

Regular doctor visit -- the doctor will check weight and blood pressure. (Doctor visits should be more frequent if diabetes is not yet controlled.)

Hemoglobin A1c test -- this lab test shows the average amount of glucose that has been in the blood over the last 3 months. It is an indicator of how well the diabetes is being controlled. (Again, this should be done more often if diabetes is not yet controlled.)

Every year

Kidney exam -- this urine test looks for "microalbumin" levels, and it should begin at puberty once the person has had diabetes at least 5 years.

Eye exam -- starting at age 10, all children with diabetes should have eyes checked once a year.

Foot exam -- the doctor should check pulse, reflexes, calluses, infections, and sores once a year. (Adults with high-risk foot conditions should be checked more frequently.)

Every 5 years

HDL/cholesterol test -- for adults, this test should be done every year, and more often if being treated for high cholesterol.

References

American Diabetes Association. Standards of medical care in diabetes--2009. Diabetes Care. 2009 Jan;32 Suppl 1:S13-61.

Alemzadeh R, Wyatt DT. Diabetes mellitus in children. In: Kliegman RM, ed. Kliegman: Nelson Textbook of Pediatrics. 18th ed. Philadelphia, Pa: Saunders;2007:chap 590.

Eisenbarth GS, Polonsky KS, Buse JB. Type 1 diabetes mellitus. In: Kornenberg HM, Melmed S, Polonsky KS, Larsen PR. Kronenberg: Williams Textbook of Endocrinology. 11th ed. Philadelphia, Pa: Saunders Elsevier;2008:chap 31.

Review Date: 6/24/2011
Reviewed By: Nancy J. Rennert, MD, FACE, FACP, Chief of Endocrinology & Diabetes, Norwalk Hospital, Associate Clinical Professor of Medicine, Yale School of Medicine, New Haven, CT. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.

© 1997- A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.